HOME > TOP STORIES
TOP STORIES
-
BUSINESS Coronavirus Woes Stymie Drug Makers’ Sales Activities in Japan, Curbs on Doctor Visits Continue
March 13, 2020
-
COMMENTARY Lenvima Heading into Megablockbuster Territory, Will Merck Tie-Up Help It Top Combined Aricept/Pariet Sales?
March 12, 2020
-
BUSINESS Drug Makers Calling Off Welcoming Ceremonies for New Hires over Coronavirus
March 11, 2020
-
REGULATORY Japan Cabinet OKs Bill to Allow Govt to Declare Emergency over Coronavirus
March 11, 2020
-
BUSINESS Japan’s 2020 Price Revision Hits Major Drugs with Double-Digit Slashes: Top 5 Product Survey
March 10, 2020
-
BUSINESS Japan’s Big 3 Generic Makers See 12.2% Price Cut vs. FY2018: Jiho Poll
March 9, 2020
-
BUSINESS Chugai, Teijin Suffer Hefty 9% Cuts in 2020 Drug Price Revision: Jiho Poll
March 6, 2020
-
REGULATORY Xolair Faces 37.3% Price Slash, Keytruda 20.9% in April: MHLW
March 5, 2020
-
BUSINESS Sumitomo Dainippon Creates Chief Scientific Officer Post to Optimize Portfolio
March 4, 2020
-
BUSINESS Vital-Net to Create 20-Strong Team of “Regenerative Medicine Liaisons”
March 3, 2020
-
BUSINESS Xolair’s Re-Pricing Decided, but Regulators and Novartis Were at Odds over Patient Projections
March 2, 2020
-
BUSINESS MSD Japan Embarking on 2-Step Spinoff for Women’s Health, Legacy Brands
February 28, 2020
-
BUSINESS Japan Drug Makers Fearing Manufacturing Crisis as Coronavirus Spreads
February 27, 2020
-
REGULATORY Zolgensma Now in Line for Japan Approval in March, All Eyes Now Riveted on Price
February 27, 2020
-
BUSINESS Fujifilm Receives Avigan Supply Requests from Overseas amid Coronavirus Outbreak
February 27, 2020
-
BUSINESS Drug Makers in Japan Upping Coronavirus Measures; Takeda Switches to Online Interviews for New R&D Hires
February 26, 2020
-
REGULATORY Japan Approves Label Expansions for Rozlytrek, Alecensa and More
February 25, 2020
-
BUSINESS “Tender Process Needs to Be Improved” in Response to Bid-Rigging Scandal by Top 4 Wholesalers: Hospital Management Advisor
February 25, 2020
-
ORGANIZATION Japan Pharma Lobbies Likely to Retain Chiefs as Off-Year Re-Pricing Debate Looms
February 21, 2020
-
BUSINESS Takeda Vaults to 9th in Global Pharma Ranking after Shire Buy, Roche Tops List: Jiho Tally
February 21, 2020
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
